This year the conference will deal with prevention and early detection – from genetic diagnosis to treatment and will focus on medical issues, new technologies and challenges for which a medical solution has yet to be found.
The conference will showcase new scientific approaches and the latest studies on early detection, accepted and futuristic treatments and breast cancer prevention.
Some of the most renowned scholars in the field will be attending – Prof. Mary Claire King from Washington University, who will be speaking about testing to identify mutations in the BRCA gene through the prism of science, Prof. Monica Morrow, from the Sloane-Kettering Medical Center in New York, will speak about the pre-op and the stage after neo-adjuvant MRI treatment, Prof. Maxine Jochelson will talk about new approaches in the field of breast cancer imaging and Shaare Zedek’s Prof. Ephrat Levy-Lahad will talk about survey testing at Shaare Zedek.
“As a leading center for breast cancer diagnosis and treatment, we are proud to host this important conference,” says Prof. Jonathan Halevy, Director-General of the Shaare Zedek Medical Center. “We are seeing impressive progress in breast cancer research, early detection and treatment. The opportunity to combine our knowledge with knowledge accumulated in other leading centers helps us to give our patients the most professional and highest quality care available.”